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Abstract
Background: Hepatitis B is a serious global public health concern. Though a safe and efficacious
recombinant vaccine is available, its use in several resource-poor countries is limited by cost. We
have investigated the production of Hepatitis B virus surface antigen (HBsAg) using the yeast Pichia
pastoris GS115 by inserting the HBsAg gene into the alcohol oxidase 1 locus.
Results: Large-scale production was optimized by developing a simple fed-batch process leading
to enhanced product titers. Cells were first grown rapidly to high-cell density in a batch process
using a simple defined medium with low salt and high glycerol concentrations. Induction of
recombinant product synthesis was carried out using rather drastic conditions, namely through the
addition of methanol to a final concentration of 6 g L-1. This methanol concentration was kept
constant for the remainder of the cultivation through continuous methanol feeding based on the
on-line signal of a flame ionization detector employed as methanol analyzer in the off-gas stream.
Using this robust feeding protocol, maximum concentrations of ~7 grams HBsAg per liter culture
broth were obtained. The amount of soluble HBsAg, competent for assembly into characteristic
virus-like particles (VLPs), an attribute critical to its immunogenicity and efficacy as a hepatitis B
vaccine, reached 2.3 grams per liter of culture broth.
Conclusion: In comparison to the highest yields reported so far, our simple cultivation process
resulted in an ~7 fold enhancement in total HBsAg production with more than 30% of soluble
protein competent for assembly into VLPs. This work opens up the possibility of significantly
reducing the cost of vaccine production with implications for expanding hepatitis B vaccination in
resource-poor countries.
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Hepatitis B virus (HBV) infection currently affects about 2
billion people worldwide. HBV, which is transmitted by
contact with blood or body fluids of an infected person
like the human immunodeficiency virus, is 50–100 times
more infectious than the latter. Perinatal HBV infections
often tend to become chronic. It is estimated that there are
more than 350 million chronic HBV carriers around the
globe. Chronic HBV infection which most often leads to
liver cirrhosis and cancer kills about a million people each
year. HBV infection represents a major human disease and
is a serious global public health concern [1,2]. This situa-
tion still prevails despite the availability of an efficacious
hepatitis B vaccine since the early eighties. The first gener-
ation vaccine was based on purified ~22 nm HBsAg-con-
taining particles from the plasma of asymptomatic HBV
carriers. Major factors that have precluded this vaccine
from mass immunization have been safety concerns,
restricted supply and high cost. The advent of a safe
recombinant hepatitis B vaccine which has helped to
reduce the cost has resulted in the inclusion of hepatitis B
vaccination in the national infant immunization sched-
ules of around 160 countries [3]. However, in many of
these countries vaccination coverage is less than 80% and
there are several countries in which the vaccine has yet to
be introduced.
Recombinant hepatitis B vaccine, based on HBsAg is being
produced in many developing countries using yeast-based
heterologous expression systems. The methylotrophic
yeast Pichia pastoris offers several advantages from the per-
spective of vaccine production. It possesses a very strong
and tightly regulated methanol-inducible alcohol oxidase
1 (AOX1) promoter which can be used to drive high-level
expression of recombinant proteins. Like E. coli it can be
cultured in simple inexpensive media. As the AOX1 pro-
moter can be controlled by manipulating the carbon
source in the medium, P. pastoris cultures can be easily
scaled up to large bioreactors. The preference of this yeast
for aerobic growth permits it to be cultured in the bioreac-
tor to cell densities exceeding 100 g L-1 cell dry mass
(CDM). All these features contribute to high productivity.
Being a eukaryote, P. pastoris is especially suitable for the
production of proteins whose functions rely on correct
disulfide bonding. Several disulfide-linked, functional
recombinant proteins have been successfully produced
using P. pastoris. Lastly, the yeast is a non-pathogenic
organism and recombinant proteins produced by it will
be free of pyrogens (unlike E. coli derived proteins), toxins
and viral inclusions (unlike mammalian cell culture
derived proteins) making them safe for human use. Con-
sequently, this yeast has emerged as a preferred host for
the production of functional recombinant proteins [4-7].
The use of P. pastoris to produce HBsAg is well-docu-
mented [8-13]. Several studies have shown that HBsAg
produced by P. pastoris assembles into characteristic ~22
nm virus-like particles (VLPs) which are highly immuno-
genic and capable of eliciting potent neutralizing antibod-
ies. An examination of the available literature reveals a
wide variation in the reported volumetric product concen-
trations of HBsAg by different groups, ranging from 0.012
to 1.0 g L-1 (Table 1). Mostly, investigators have used MutS
(methanol utilization slow) strains of P. pastoris created by
replacing the host AOX1 gene with the HBsAg gene under
the control of the native AOX1 promoter. In general, fed-
batch protocols developed for large-scale production of
recombinant proteins, including HBsAg, by P. pastoris,
consist of a batch phase with growth on glycerol as carbon
source, followed by a glycerol-limited fed-batch proce-
dure to increase the biomass concentration and derepress
the AOX1 promoter, and, finally, concluded by the induc-
tion phase using different methanol feeding protocols.
In this work, we present a simple fed-batch protocol
developed for high-level production of recombinant pro-
teins by P. pastoris and the application of this procedure
for the intracellular production of HBsAg. We demon-
strate that our simple cultivation process resulted in ~7
fold enhancement in total HBsAg production compared
Table 1: HBsAg production with P. pastoris
Strain (copy#) MeOH (%) Induction time (h) VLP (method)a Quantification Yield (g L-1) Reference
Muts (1) 0.5 200 + (RIA; EM) Western 0.4 [11]
Muts (8) 0.1 192 + (E) Western 1.0 [10]
nd (nd)b nd nd Nd E 0.097 [12]
Muts (nd) 0.5 96 + (EM) nd nd [9]
Muts (nd) 1.0 72 Nd RPHAc 0.0125 [8]
Muts (nd) 0.1 70 Nd E 0.32 [13]
Mut+ (nd) 0.25 50 Nd E 0.35 [13]
Muts (8) 0.6 90–160 + (EM) RP-HPLC 6–7 present study
a The '+' symbol denotes detection of virus-like particles (VLP) using radioimmunoassay (RIA), electron microscopy (EM) or ELISA (E)
b nd indicates no data available
c RPHA: reversed passive hemeagglutination assayPage 2 of 8
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being soluble protein, competent for assembly into VLPs.
Results
A simple two-stage fed-batch cultivation technique was
adopted for the production of HBsAg using P. pastoris
GS115 as expression host. The cells were first grown at
30°C (pH 5.5) in a batch procedure using a simple
defined medium containing low salt and high glycerol
concentration (95 g L-1). Using this medium final biomass
concentrations of ~60 g L-1 CDM were obtained at the end
of the batch phase (Fig. 1A) corresponding to a biomass
yield coefficient (YX/S) = 0.61 g g-1 (CDM on glycerol).
During the batch phase, a maximum specific growth rate
(μmax) = 0.17 h-1 was reached. After depletion of glycerol
(Fig. 1A), induction of HBsAg production was initiated by
the addition of methanol (Fig. 1B). The end of the batch
phase was indicated by a sudden increase in the dissolved
oxygen (DO) concentration (Fig. 1D) and decrease of the
respiratory activity (Fig. 1E). During the fed-batch HBsAg
production phase, methanol was the sole carbon and
energy source and its concentration was kept constant at 6
g L-1 by continuous feeding based on the signal from a
flame ionization detector (FID) employed for on-line
monitoring of the methanol concentration (Fig. 1B). After
the sudden exposure of P. pastoris to methanol, biomass
Two-phase fed-batch cultivation of P. pastoris GS115 carrying 8-copies of the HBsAg gene under the control of the AOX1 pro-moterFigu e 1
Two-phase fed-batch cultivation of P. pastoris GS115 carrying 8-copies of the HBsAg gene under the control of 
the AOX1 promoter. Cells were first grown in a batch phase with glycerol as carbon source followed by a methanol feeding 
phase to induce the production of HBsAg. (A) Concentrations of glycerol (filled squares) and biomass (optical density: filled cir-
cles; cell dry mass: filled triangles). (B) Concentration of methanol (solid line) and amount of methanol added to the bioreactor 
(dashed line). (C) Medium pH (solid line) and amount of ammonium hydroxide added to the bioreactor (dashed line). (D) Dis-
solved oxygen concentration (solid line), aeration rate (dotted line), and stirrer speed (dashed line). (E) Oxygen transfer 
(dashed line) and carbon dioxide evolution (solid line) rates and respiratory quotient (dotted line). Small arrows indicate 
removal of culture broth. (F) Cell growth (filled circles) and accumulation of HBsAg (total HBsAg: filled squares and soluble 
HBsAg: open squares). The dashed vertical line indicates the end of the glycerol batch and the start of the methanol feeding 
phase.Page 3 of 8
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resumed after a short period of adaptation (~3–4 h, Fig.
1A). Successful adaptation to methanol was also noticea-
ble by the onset of automated methanol feeding (Fig. 1B),
the resumption of ammonia uptake (Fig. 1C), the increase
in the respiratory activity (Fig. 1E), and the increased stir-
rer speed in response to the elevated oxygen demand (Fig.
1D). After the onset of methanol feeding, biomass con-
centrations increased from 60 g L-1 to ~100 g L-1 CDM after
90–100 h of growth on methanol. Further extension of
the fed-batch phase did not result in more growth but led
to growth cessation and finally to cell lysis as indicated by
decreasing biomass concentrations (Fig. 1A). Moreover,
cell viability remained high during the first 90–100 h of
growth on methanol (> 90%), but declined considerably
beyond (data not shown).
Recombinant HBsAg production was analyzed during the
induction phase from culture aliquots withdrawn at vari-
ous time points. The analysis of total cell lysates by SDS
PAGE and Western blot demonstrated that HBsAg accu-
mulated as the most prominent protein band of the total
cell protein (Fig. 2). Quantification of HBsAg production
by RP-HPLC revealed that total HBsAg concentrations
reached a maximum of 7 g L-1 (Fig. 1F). The productivity
was highest during the first 90–100 h of growth on meth-
anol. Continuation of the induction phase resulted only
in a slight increase in the volumetric concentration of total
HBsAg. The amount of soluble HBsAg competent for VLP
assembly represented about 30% of total HBsAg reaching
highest concentrations of 2.3 g L-1 after 90–100 h of
growth on methanol (Fig. 1F). Again, extending the meth-
anol feeding phase beyond 90–100 h did not increase the
amount of soluble HBsAg but caused a slight decline in
the concentration of HBsAg competent for VLP assembly.
Finally, analysis of negatively stained, purified HBsAg by
electron microscopy revealed the appearance of character-
istic VLPs (Fig. 2), a prerequisite of HBsAg applicability for
human vaccination against Hepatitis B [11,14-16].
Discussion
Currently, most P. pastoris fed-batch cultivations for pro-
duction of recombinant proteins using the AOX1 expres-
sion system consist of three or four distinct phases [17-
19]. The generation of biomass is achieved by growing the
cells in two phases using glycerol as carbon substrate
[17,19]. Initially, the cells are grown on glycerol in batch
mode. For this phase, a maximum level of 40 g L-1 glycerol
is recommended due to potential inhibitory effects of ele-
vated glycerol concentrations [19]. After consumption of
glycerol, a glycerol-limited feeding phase follows until the
desired level of biomass is reached. A glycerol-limited
feeding phase has been also considered necessary for dere-
pression of the AOX1 promoter, preparing cells for effi-
cient production during the methanol fed-batch phase
[17]. After reaching the desired biomass concentration,
methanol-feeding is initiated to start recombinant protein
production [17]. In Muts cultivations it is recommended
to keep the methanol concentration below 3 g L-1 [19,20]
and, independent of the phenotype, it has been advised to
keep the methanol concentration below 4 g L-1 [18]. A
variety of different methanol feeding strategies have been
Time-course analysis of HBsAg productionF gure 2
Time-course analysis of HBsAg production. (A) Total cell lysates analyzed by SDS-PAGE from samples taken directly 
before the addition of methanol (time 0) and 2, 4, 6, 8, 10, 22, 30, 44, 104, and 164 hours after the onset of methanol feeding. 
(B) Western blot analysis of total cell lysates taken directly before the addition of methanol (time 0) and 22, 44, 104, and 164 
hours after the onset of methanol feeding using a commercially available rabbit anti-HBsAg antiserum. The bidirectional arrow 
between panels A and B denotes the position of the HBsAg. (C) Transmission electron microscopic survey of negatively 
stained, purified HBsAg particles.
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ing conditions preventing or even allowing the occurrence
of oxygen limitation [21,22]. Some protocols even advo-
cate two-phase induction strategies [23,24]. Sometimes
mixed (methanol-glycerol) feeding protocols are also sug-
gested for a more smooth methanol adaptation [17] or
decaying temperature profiles during the induction phase
to reduce proteolysis and cell death [24]. A comparison of
the performance of these different fed-batch strategies is
difficult, in particular, when different recombinant pro-
teins are produced. In contrast to these multi-phase proto-
cols we propose a simple two-phase strategy that only
includes a glycerol batch phase, to generate sufficient bio-
mass, directly followed by the induction phase with a con-
stant methanol concentration for the remainder of the
cultivation, to achieve high-level production of the
recombinant protein.
Thus, we have combined the first two phases of growth on
glycerol into a single phase by using higher glycerol con-
centration than those recommended previously. Moreo-
ver, we used a lower salt concentration as usually
suggested [19] to decrease the osmolarity of the medium.
When aiming at low osmolarity, the nitrogen supply can
be critical in high-cell density Pichia cultivations. To keep
the osmolarity low, a low initial nitrogen concentration
was chosen and ammonium hydroxide was employed for
pH control, and thus, the majority of nitrogen was not
added at the start, but during the cultivation (Fig. 1C).
In addition, we could show that a glycerol fed-batch phase
is not required for adaptation to methanol. At the end of
the glycerol batch phase after switching to methanol, cell
growth is resumed after a short period of adaptation (~3–
4 h, Fig. 1). This adaptation period is not longer than
observed with a preceding glycerol-limited feeding phase
[25,26].
Prevention of high methanol concentrations in Pichia cul-
tivations has been advocated by many authors as this
might lead to the generation of toxic products such as for-
maldehyde and hydrogen peroxide which may compro-
mise cell viability and productivity [20,27]. Other groups
noticed growth-inhibitory effects only at methanol con-
centrations >2% and recommended up to 1% methanol
to induce foreign protein production [27,28]. As a com-
promise between the positive effect of high methanol con-
centrations on induction strength and the negative effect
on cell viability emerges a methanol concentration of 0.4–
0.6% as is reported in our study and also by other groups
[29].
P. pastoris is an obligate aerobe, and thus, oxygen availa-
bility is of critical importance. In the past, it has been
strongly advised to prevent oxygen limiting conditions in
high-cell density Pichia cultures, either by reducing the
methanol supply [20] or enriching the inlet air with pure
oxygen. More recently, however, it has been shown that
reduced oxygen supply may be even advantageous for the
production of recombinant proteins using the P. pastoris
AOX1 expression system [23,25,26,30]. This is in agree-
ment with our observation that there is no need to enrich
the inlet air with pure oxygen or reduce the methanol sup-
ply to prevent oxygen limiting conditions during the
induction phase to reach high-level production of HBsAg
(Fig. 1D).
In conclusion, a simple two-phase high-cell density fed-
batch procedure composed of a glycerol batch and a con-
stant methanol fed-batch phase based on robust FID on-
line analytics is proposed that generates ~7 times more
HBsAg than previously reported using Pichia based expres-
sion systems.
Methods
Strain and preparation of precultures
The MutS strain of P. pastoris GS115 carrying 8-copies of
the HBsAg gene under the control of the AOX1 promoter
has been described before [31]. A 1-L preculture was pre-
pared in two stages as follows. First, a 20-mL pre-precul-
ture was prepared using 20 μL of the stock culture which
was grown at 30°C in an orbital shaker (Multitron II,
Infors AG, Germany) at 150 rpm for 48 h. This preculture
was used to inoculate a 1-L preculture that was grown for
17 h, to serve as inoculum for the bioreactor culture. Cul-
tures were grown in basal medium, in baffled flasks whose
volumes were ~5× the culture volume to permit adequate
aeration. The basal medium containing glycerol (20 g L-1),
yeast nitrogen base (13.4 g L-1) and biotin (400 μg L-1)
was prepared in MilliQ water.
High-cell density fed-batch cultivation, culture conditions 
and control
Cultivation was carried out in a 15 L BIOSTAT-C (B. Braun
Biotech International, Germany) bioreactor interfaced
with UBICON for data acquisition and control. A 1-L
inoculum, prepared as described above, was transferred to
the bioreactor containing 9 L growth medium. The growth
medium contained per liter: glycerol, 95.2 g; potassium
di-hydrogen phosphate, 9.4 g; yeast trace metal (YTM)
solution, 1.14 g; ammonium sulfate, 15.7 g; magnesium
sulfate hepta-hydrate, 1.83 g; calcium chloride di-hydrate,
0.28 g; and biotin, 0.4 mg. The YTM solution contained:
potassium iodide, 207.5 mg L-1; manganese sulfate, 760.6
mg L-1; di-sodium molybdate, 484 mg L-1; boric acid, 46.3
mg L-1; zinc sulfate hepta-hydrate, 5.032 g L-1; ferric chlo-
ride hexa-hydrate, 12.0 g L-1; and sulfuric acid, 9.2 g L-1.
Antifoam (Ucolub N115) was added manually to control
foaming in the bioreactor. Temperature was maintained
at 30°C and pH at 5.6 with 12.5% (v/v) NH4OH. AerationPage 5 of 8
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stirrer speed was controlled between 100 to 1370 rpm
aiming at DO concentration of 20% air saturation. After
consumption of glycerol, indicated by an increase of the
DO concentration, production of recombinant HBsAg
was initiated by the addition of a methanol solution
[98.6% (w/w) methanol and 1.4 % (w/w) YTM] to a final
methanol concentration of 6 g L-1. For the remainder of
the cultivation, the methanol concentration was kept at 6
g L-1 in the culture medium based on on-line measured
methanol concentrations determined from the methanol
vapor in the off-gas using a FID (Ratfish Instruments, Ger-
many). Based on the gas liquid phase equilibrium metha-
nol concentrations were determined in the off-gas using
two point calibrations directly before and after induction.
The concentrations of oxygen and carbon dioxide in the
exhaust gas were determined by paramagnetic and infra-
red exhaust gas analysis systems, respectively (Maihak,
Hamburg, Germany).
Determination of cell concentration
The cell concentration was determined by measuring the
optical density (OD) at 600 nm, of suitably diluted cul-
tures, using a Novaspec II spectrophotometer (Pharmacia
LKB). For CDM determination, 1 mL aliquots of the cul-
ture broth were centrifuged (13,000 rpm for 15 min at
room temperature using an Eppendorf microcentrifuge,
model 5415C) in pre-weighed tubes, re-suspended in 50
mmol L-1 phosphate buffer, pH 7.2, re-centrifuged and the
resultant pellets vacuum-dried at 80°C (Heraeus Instru-
ments, Vacutherm) to constant mass. CDM was measured
in triplicates and averaged. Cell viability in aliquots with-
drawn at different time points during the cultivation was
assessed by flow cytometry as described before [30].
Determination of glycerol concentration
Glycerol concentrations in culture samples were deter-
mined using glycerol test kits (Roche, Basel, Switzerland).
Briefly, 1-mL culture samples were centrifuged (13,000
rpm for 15 min at 4°C) and the glycerol concentration in
the supernatant was analyzed in duplicate.
Preparation of total cell extracts
Samples corresponding to 100 OD units (1 mL) were
transferred and pelleted by centrifugation at 13,000 rpm
for 15 min. The cell pellet was washed using 1 mL 10
mmol L-1 phosphate buffer, pH 7.2 and mixed with 0.6 g
glass beads of 0.45 mm diameter suspended in 500 μL of
lysis buffer [10 mmol L-1 phosphate buffer, pH 8, 5 mmol
L-1 EDTA, 500 mmol L-1 NaCl, 8% (v/v) glycerol]. The cells
were lysed by 20 cycles of 1-min vortexing at maximum
speed followed by 4–5 min chilling on ice. After the final
cycle of vortexing and chilling, the lysate was transferred
into a fresh tube. The glass beads were rinsed twice with
lysis buffer and pooled with the initial lysate to obtain a
final volume of 1 mL.
SDS-PAGE and Western blot analyses
A 50 μL aliquot of this lysate was mixed with an equal vol-
ume of a modified SDS sample buffer [5% (w/v) SDS,
50% (v/v) β-mercaptoethanol, 0.5 mol L-1 DTT, 3% (v/v)
glycerol], vortexed for 1 min and boiled for 15 min and
then analyzed on a 15% SDS-polyacrylamide gel (10 μL
loaded per lane). To visualize polypeptide profiles of the
lysates before and after induction, the gels (run at 150 V
for 80 min) were stained using Coomassie colloidal blue
silver [32]. For Western blot analysis, the separated pro-
teins were electro-transferred to PVDF membranes (pre-
treated with methanol and washed with transfer buffer) at
100 V for 90 min. The PVDF membrane with the electro-
transferred proteins was blocked for 1 h at room temper-
ature, in phosphate buffered saline containing 1% (v/v)
Tween 20, 5% (w/v) skim milk and 2% (w/v) polyvinyl
pyrrolidone. HBsAg was detected in the blot using a com-
mercially available rabbit polyclonal anti-HBsAg antise-
rum (Acris Antibodies GmbH, Germany) in conjunction
with anti-mouse IgG-alkaline phosphatase conjugate and
BCIP/NBT substrate (Calbiochem, La Jolla, CA).
Determination of protein concentration
Protein content of P. pastoris total cell extracts was esti-
mated by Pierce bicinchoninic acid (BCA) method [33].
Determination of soluble and total HBsAg
VLPs in the clarified extracts (soluble HBsAg) were deter-
mined using the particle-specific quantitative Hepanos-
tika micro ELISA system (Hepanostika Ultra Elisa,
Biomerieux, France). Prior to the assay, the total cell
extracts were processed as follows. Tween 20 was added to
the extract to a final concentration of 1% (v/v) followed
by vortexing at maximum speed for 4 hours at room tem-
perature, to permit maximal solubilization of the rcom-
binant HBsAg. The samples were centrifuged at maximum
speed at room temperature for 10 min. The resultant
supernatant was then diluted 20,000-fold with 0.1% (w/
v) bovine serum albumin in phosphate buffered saline.
This material was used in the Hepanostika micro ELISA.
In-house HBsAg ranging in concentrations from 1–100 ng
mL-1 was processed in parallel. The in-house HBsAg stand-
ard was pre-calibrated against NIBSC reference (second
international standard: code – 00/588).
Total HBsAg was determined by reversed phase-high per-
formance liquid chromatography (RP-HPLC) as reported
earlier [34]. For this, a 100-μL aliquot of the P. pastoris cell
lysate was suspended in an equal volume of solubilization
reagent [8% (w/v) SDS, 50% (v/v) β-mercaptoethanol, 1
mol L-1 DTT] boiled for 15 min and clarified by centrifu-
gation and filtration. A 50 μL aliquot of this clarified sam-Page 6 of 8
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column (3.3 cm × 4.6 mm), maintained at 70°C in HPLC
column oven (CH – 500, Eppendorf, Germany), at a flow
rate of 1 mL min-1 using buffer A [0.15% trifluroacetic acid
(v/v) in MilliQ water] and buffer B (2-propanaol:ace-
tonitrile in 80:20 ratio) which were used to generate a gra-
dient in which the percentage of buffer B changed with
time as follows: 0–4 min, 45%; 4–10 min, 45–95%; 10–
13 min, 95%; 13–14 min, 95–45%; 14–18 min, 45%. The
entire process was performed using a Shimadzu liquid
chromatography system equipped with an auto-injector
(SIL-10 AD VP), UV-VIS detector (SPD-10A), pumps A
and B (LC-10 AT VP) and controller (SCL-10 A VP). All the
samples were analyzed at 214 nm.
Electron microscopic analysis of HBsAg VLPs
Purified HBsAg VLPs were diluted with PBS-buffer (7
mmol L-1 K2HPO4; 14 mmol L-1 NaH2PO4; 130 mmol L-1
NaCl, pH 7.2) to a final protein concentration of 50 μg
mL-1, adsorbed for 2 minutes to a glow-discharged C-
Formvar foil and negatively stained with 2% (w/v) urany-
lacetate, pH 4.5. Electron microscopic examination was
done as described before [35]. An energy-filtered trans-
mission electron microscope Libra 120 (Zeiss, Oberko-
chen, Germany) was used and zero-loss images were
taken with a 2048 × 2048 CCD camera (Tröndle, Mooren-
weis, Germany) using an energy-width of 15 eV and an
objective aperture of 90 μm.
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